Company profile
Longevity Health Holdings Inc.
OTC: XAGE · Healthcare · Biotechnology
#805 of 1,417 Healthcare companies by revenuetop-decile growth
EA Score
22DFH 26DQ 15GM —SS 23
v0.1 · 55/100 weight · provisional
↑ revenue growth (YoY), Piotroski F · ↓ disclosure history, return on assets
Methodology →Revenue TTM
$1.7M
Rev growth YoY (TTM)
+60.3%
Net income (FY)
-$6.9M
Employees
10
as of 2026-08-27
Market cap
$318.8k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.9M$1.9M2025
Net income-$6.9M-$6.9M2025
Operating income-$7.1M-$7.1M2025
Total assets$2.4M$2.4M2025
Liabilities$8.2M$8.2M2025
Equity-$5.9M-$5.9M2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Longevity Health Holdings Inc.’s revenue?
Longevity Health Holdings Inc. booked $1.9M in FY2025 revenue, growing 3701% year over year — faster than 98% of Healthcare companies we track, at a -361.0% net margin.
Peers · Healthcare
THC Biomed Intl Ltd.——iSpecimen Inc.29DAnteris Technologies Global Corp.32DVeltex Corporation50DBio Essence Corporation52DResonate Blends, Inc.——Neighbors
Allegheny →Key facts
CEOJanakiram Ajjarapu
SectorHealthcare
IndustryBiotechnology
HeadquartersPittsburgh, PA
ExchangeOTC: XAGE
Employees10
IPO date2021-09-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.